The long road to optimal management for chronic granulomatous disease

Affiliations

¹ Division of Immunology and the Manton Center for Orphan Disease Research, Boston Children's Hospital, Boston, Mass; Harvard Stem Cell Institute, Harvard Medical School, Boston, Mass. Electronic address: luigi.notarangelo@childrens.harvard.edu.

Editorial

Luigi D Notarangelo. J Allergy Clin Immunol. 2013 Nov.

. 2013 Nov;132(5):1164-5.

doi: 10.1016/j.jaci.2013.08.035. Epub 2013 Oct 4.

¹ Division of Immunology and the Manton Center for Orphan Disease Research, Boston Children's Hospital, Boston, Mass; Harvard Stem Cell Institute, Harvard Medical School, Boston, Mass. Electronic address: luigi.notarangelo@childrens.harvard.edu.

No abstract available

Keywords: Chronic granulomatous disease; clinical outcome; hematopoietic cell transplantation; oxidase activity.

Comment on

Clinical outcome in children with chronic granulomatous disease managed conservatively or with hematopoietic stem cell transplantation.
Cole T, Pearce MS, Cant AJ, Cale CM, Goldblatt D, Gennery AR. Cole T, et al. J Allergy Clin Immunol. 2013 Nov;132(5):1150-5. doi: 10.1016/j.jaci.2013.05.031. Epub 2013 Jul 16. J Allergy Clin Immunol. 2013. PMID: 23870668
Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients.
Köker MY, Camcıoğlu Y, van Leeuwen K, Kılıç SŞ, Barlan I, Yılmaz M, Metin A, de Boer M, Avcılar H, Patıroğlu T, Yıldıran A, Yeğin O, Tezcan I, Sanal Ö, Roos D. Köker MY, et al. J Allergy Clin Immunol. 2013 Nov;132(5):1156-1163.e5. doi: 10.1016/j.jaci.2013.05.039. Epub 2013 Jul 31. J Allergy Clin Immunol. 2013. PMID: 23910690